Share this article and save a life!
40 million people ask ChatGPT for health advice daily. Now it’s official.
OpenAI just dropped ChatGPT for Healthcare with full HIPAA compliance, and the early adopter list reads like a who’s who of American medicine:
• AdventHealth
• Boston Children’s Hospital
• Cedars-Sinai
• HCA Healthcare
• Memorial Sloan Kettering
• Stanford Children’s Health
• UCSF
Here’s what makes this different from every other AI announcement:
At Penda Health, their clinical copilot reduced both diagnostic AND treatment errors in live primary care settings. Not in a trial. Not in a simulation. In actual patient care with real clinicians making real decisions.
70% of ChatGPT health conversations happen outside clinic hours.
Half of U.S. nurses are already using AI weekly.
Yet we’re still debating whether AI belongs in healthcare?
The real question isn’t whether AI will transform healthcare. It’s whether traditional health systems can move fast enough to keep up with consumer expectations.
Think about it: patients are already getting AI health guidance at 2 AM on their phones. Meanwhile, many hospitals still fax medical records.
The gap between what patients expect and what healthcare delivers has never been wider.
This isn’t just about technology adoption. It’s about reimagining the entire care delivery model around AI-augmented workflows, 24/7 availability, and instant information synthesis.
Health systems that embrace this shift will thrive.
Those that don’t? They’ll become the Blockbuster of healthcare.
♻️ Repost if AI should augment, not replace, human clinical judgment
👉 Follow me, Jonathan Govette, for real-time updates on healthcare technology and business news. LinkedIn Profile: https://www.linkedin.com/in/jonathangovette/
Share this article and save a life!
Author:
Jonathan Govette is a seasoned healthcare and technology executive with more than two decades of experience building, scaling, and advising digital health companies. He is the Co-Founder and CEO of Oatmeal Health, an AI-driven Lung Cancer Screening and Diagnostics company focused on expanding access to early detection for underrepresented populations, particularly patients served by Federally Qualified Health Centers and value-based health plans.
With a background in engineering, product development, and strategic partnerships, Jonathan has founded and led multiple health technology ventures across clinical care delivery, regulated medical software, and AI-enabled diagnostics. His work sits at the intersection of medicine, technology, and health equity, with a consistent focus on translating complex clinical problems into scalable, real-world solutions.
Jonathan has spent much of his professional life dedicated to improving outcomes for marginalized and underserved communities. He has designed and implemented frameworks that align clinical quality, reimbursement, and technology to sustainably advance health equity at scale. This mission is deeply personal and informs his leadership philosophy and long-term vision for healthcare transformation.
In addition to his operating experience, Jonathan is an author and long-time writer in the healthcare domain, with over 20 years of published work covering digital health, medical innovation, and healthcare systems. He is a frequent mentor to early-stage founders and regularly advises startups on product strategy, partnerships, and go-to-market execution in regulated healthcare environments.
Before entering industry full-time, Jonathan nearly pursued a career in medicine with an early path toward cardiothoracic surgery, an experience that continues to shape his clinical perspective and respect for frontline care delivery.
CEO | Oatmeal Health | AI Lung Cancer Startup | Engineer | Writer | Almost Became a Doctor (Cardiac Thoracic Surgeon) | 3x Health Tech Founder | Startup Mentor | Follow to share what I’ve learned along the way.
